gvtcx

Provision of MagNA Pure 96

Public Health England Published 3 Jun 2021 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£358,297
Statuscomplete
Category (CPV) 33100000
Deadline26 Apr 2021
Contract start21 May 2021
Contract end20 May 2022
Procedureselective
SME suitableYes
OCIDocds-b5fd17-f4ce319c-2de9-4a8f-b0c3-b54a80411fd1

Award

SupplierValueDateStatus
ROCHE DIAGNOSTICS LIMITED £358,297 20 May 2021 active

description

Public Health England (PHE) has awarded a contract to Roche Diagnostics Limited to procure MagNA Pure 96.

This is part of a critical project to rapidly expand the SARS-CoV-2 sequencing capacity under the Genomics testing expansion slated for the 2nd half of 2021.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
3 Jun 2021 Award (award) · 5a396c24-2f08-45e1-8d6f-62f4af1567dd-440950

more from Public Health England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.